Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Total-Cashflows-From-Investing-Activities" stands at -0.1824 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.2147 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is 0.2147 Trillion Japanese Yens.
The 3 year change is 0.0422 Trillion Japanese Yens.
The 5 year change is -0.167 Trillion Japanese Yens.
The 10 year change is -0.2074 Trillion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Cashflows From Investing Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Cashflows From Investing Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Cashflows From Investing Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Cashflows From Investing Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Cashflows From Investing Activities | 280,205,508,085.11 |